Free NHA Phlebotomy Technician Certification Exam (CPT) Phlebotomy-Technician Exam Questions

For a CBC and basic metabolic panel, the green-top tube should be collected before the lavender-top tube when following the standard order of draw after sterile/blood culture tubes and coagulation tubes. A basic metabolic panel is commonly collected in a green-top heparin tube or serum tube depending on facility protocol, while a CBC requires a lavender-top EDTA tube. Additive carryover is the key concept. EDTA from a lavender tube can contaminate later specimens and falsely elevate potassium while lowering calcium because EDTA binds calcium. This makes lavender-top collection before chemistry specimens technically unsafe when chemistry testing is also ordered. Gray-top tubes are generally used for glucose or lactate testing and are collected later. Yellow SPS tubes are used for blood cultures and would be collected first only if blood cultures were ordered. The phlebotomist must know order of draw, tube additives, and the clinical consequence of additive contamination. Reference topics: Routine Blood Collections; order of draw; tube additives; CBC; chemistry specimen collection.

Before using evacuated vacuum tubes, the phlebotomist must verify the expiration date. Expired tubes can lose vacuum, produce inadequate draw volume, compromise the blood-to-additive ratio, or contain additives that no longer perform as intended. This can directly affect specimen integrity and may lead to inaccurate results or specimen rejection. Needle integrity is also important, but it applies to needle inspection rather than vacuum tube quality control. Visible additive may be observed in some tubes, but not all additives are easily visible, and visibility alone does not confirm the tube is acceptable for use. Name on label is not checked before using an unused tube because patient labeling occurs after collection according to facility policy and positive patient identification requirements. Tube quality control includes inspecting tubes for cracks, contamination, expired dates, defective stoppers, and compromised vacuum. NHA CPT routine collection content specifically includes selecting and assembling equipment, verifying equipment quality, checking expiration dates, and inspecting evacuated tubes required for laboratory testing. Reference topics: Routine Blood Collections; evacuated tube quality control; expiration dates; equipment inspection.

Quality control testing should be performed before using a new lot number of point-of-care testing strips. Lot-to-lot variation can affect test performance, and QC confirms that the strips, controls, meter, and operator process are producing acceptable results before patient testing begins. Freezing strips is incorrect unless a manufacturer specifically requires a storage condition, and most reagent strips have controlled storage requirements that must not be improvised. Mixing old and new lots is unsafe because it creates traceability problems and can invalidate quality control. Using strips only for ''control patients'' is meaningless; patient specimens should not be used to validate unverified supplies. For waived testing and point-of-care testing, the phlebotomist must follow manufacturer instructions, document QC results, check expiration dates, store materials properly, and stop patient testing when controls fail. If QC is outside range, patient results should not be reported until corrective action is completed. Reference topics: Safety and Compliance; Special Collections; point-of-care testing; quality control; reagent lot verification.

When preparing a specimen for transport, the phlebotomist should keep the tube with the stopper upright whenever practical. Upright positioning helps reduce leakage risk, prevents specimen contact with the stopper area more than necessary, and supports safe handling during movement to the laboratory or processing area. Refrigerating infectious substances is not a universal transport rule; temperature requirements depend on the ordered test and specimen handling instructions. Agitating a tube vigorously is incorrect because it can cause hemolysis, clot disruption, foaming, or cellular damage. Additive tubes are mixed by gentle inversion according to manufacturer guidance, not shaking. Wrapping multiple tubes together is also poor practice because tubes should be protected from breakage, leakage, and cross-contamination using proper specimen transport bags, absorbent material when required, and separated compartments when applicable. Proper transport preserves analyte stability, patient safety, and biohazard control. NHA CPT processing content includes preparing specimens for testing or transport, maintaining specimen integrity based on temperature, light, or time requirements, and following handling, storage, transportation, and disposal requirements. Reference topics: Processing Specimens; specimen transport; tube handling; specimen integrity.

A midstream clean-catch urine specimen requires use of a sterile specimen container because the purpose is to reduce contamination from skin flora, genital secretions, and environmental organisms. The patient is instructed to clean the area using the facility-provided cleansing materials, begin voiding, then collect the midstream portion without touching the inside of the container or lid. Filling the container to the lid is not required and can create leakage, contamination, or transport problems. Labeling the lid is incorrect because the label must be placed on the specimen container itself; lids can be separated or switched. Cleansing with alcohol wipes is also not the standard answer because urine collection kits typically use antiseptic cleansing towelettes designed for clean-catch collection, not alcohol as the defining requirement. The phlebotomist must provide clear patient instructions and verify that the specimen is properly labeled and handled. The NHA CPT outline includes non-blood specimen collection, patient instructions for urine specimens, specimen handling, and processing requirements. Reference topics: Special Collections; non-blood specimen collection; urine specimen instructions; specimen integrity.

The best initial introduction is to knock on the door, greet the patient, and introduce themselves. This sequence respects privacy, establishes professional presence, and begins communication before any technical identification or collection step. Entering quietly without first knocking may be inappropriate in a patient-care environment because the patient has a right to privacy and dignity. Turning on lights immediately can be abrupt, especially for hospitalized patients who may be resting, anxious, or ill. Checking the ID band is essential, but it follows professional entry and introduction. Checking the provider's prescription or order is important before collection, but it is not the interpersonal ''initial introduction'' step at bedside. The correct approach supports patient cooperation, consent, and safety. After introduction, the phlebotomist should verify the order, use two identifiers, explain the procedure, assess patient readiness, and obtain consent according to facility policy. Reference topics: Patient Preparation; therapeutic communication; patient rights; bedside approach; patient identification; consent. NHA's CPT test plan includes patient communication and preparation as a major domain.

For antecubital venipuncture, the needle is inserted bevel up at approximately a 15 to 30 angle, with 30 commonly used as the upper accepted standard for routine venous access. From the options provided, 30 is the best answer. A 10 angle is usually too shallow for antecubital venipuncture and may cause the needle to skim the skin surface or fail to enter the vein lumen. A 45 angle is too steep and increases the risk of passing through the vein, causing hematoma, pain, or arterial/nerve injury depending on site depth and anatomy. A 25 angle can be clinically workable in some routine venipunctures, but this item is asking for the standard recognized insertion angle, and 30 is the expected test answer. Proper angle must be combined with vein anchoring, bevel-up orientation, stable equipment control, and avoidance of excessive probing. The NHA CPT outline specifically includes needle insertion, angle of needle insertion and withdrawal, and routine venipuncture technique. Reference topics: Routine Blood Collections; antecubital venipuncture; angle of needle insertion; needle withdrawal and safety.

The best response is, ''Your provider can explain what the result means.'' Phlebotomists may explain collection procedures, specimen requirements, and general process steps, but they should not interpret laboratory results, diagnose conditions, or speculate about disease severity. Telling the patient the condition is serious is outside scope and may be inaccurate. Advising the patient to search online is unprofessional and can increase confusion or anxiety. Suggesting the laboratory made an error is also inappropriate unless an authorized investigation has identified an error. The correct response protects patient safety, scope of practice, and communication integrity. Laboratory results must be interpreted in clinical context, including history, medications, symptoms, other test results, and provider assessment. The phlebotomist should route result questions to the ordering provider or authorized clinical staff according to facility policy. This question tests professionalism and communication boundaries. Reference topics: Patient Preparation; scope of practice; patient communication; result interpretation; professional conduct.

The phlebotomist should use an approved alternate identification process. If a patient cannot reliably state their date of birth because of confusion, cognitive impairment, language barrier, or illness, the technician must follow facility policy for identification. This may involve a caregiver, legal guardian, identification band, photo identification, nurse verification, or other approved method depending on the setting. Proceeding using the requisition only is unsafe because the requisition is not the patient. Asking the patient to guess is obviously unreliable and creates wrong-patient risk. Labeling the specimen later in the laboratory is also unsafe because labeling must occur immediately after collection in the patient's presence or according to strict facility procedure. Accurate patient identification is the first major defense against specimen mislabeling, wrong diagnosis, wrong treatment, and patient harm. The phlebotomist must not improvise identity verification just to keep workflow moving. Reference topics: Patient Preparation; patient identification; alternate identification; outpatient collection; specimen labeling.

An underfilled collection tube is a common reason for laboratory rejection because many tests require a specific blood-to-additive ratio. This is especially critical for coagulation specimens, where insufficient blood relative to anticoagulant can falsely prolong clotting results. Underfilling can also produce inadequate specimen volume for testing, repeat analysis, or instrument requirements. A hematoma at the puncture site is a patient complication and may indicate procedural difficulty, but it does not automatically require specimen rejection unless it affected specimen quality. Use of a multiple-sample needle is a standard venipuncture method and is not a rejection criterion by itself. The cephalic vein is an acceptable antecubital vein when selected appropriately, so using it does not invalidate the specimen. Processing accuracy begins at collection: correct tube, correct volume, correct mixing, correct labeling, and correct transport. The NHA CPT outline identifies preanalytical errors, minimum and maximum volume requirements, fill levels and ratios, maintaining specimen integrity, and recollection as core processing and collection competencies. Reference topics: Processing Specimens; preanalytical errors; tube fill level; specimen rejection and recollection.